PT UBC Medical Indonesia Tbk (IDX:LABS)
Indonesia · Delayed Price · Currency is IDR 121.00
-1.00 (-0.82%)
Nov 5, 2026, 3:39 PM WIB
IDX:LABS Financials Overview
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 214,405 | 199,295 | 147,637 | 136,699 | 93,292 | 129,960 |
Revenue Growth | 21.38% | 34.99% | 8.00% | 46.53% | -28.21% | - |
Gross Profit Gross Profit Growth | 83,141 | 79,198 | 56,755 | 54,564 | 37,156 | 49,431 |
Operating Income Operating Income Growth | 18,345 | 20,366 | 8,952 | 5,844 | 3,398 | 3,191 |
Net Income Net Income Growth | 8,730 | 13,507 | 2,952 | 2,190 | 2,834 | 308.25 |
Earnings Per Share EPS Growth | 2.23 | 3.42 | 0.75 | 0.93 | - | - |
EPS Growth | -5.25% | 357.50% | -19.63% | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medical Disposable and Consumables Medical Disposable and Consumables Growth | 208,373 | 185,556 | 142,487 | 103,170 | 78,067 | 122,154 |
Diagnostic and Equipment Diagnostic and Equipment Growth | 7,293 | 13,739 | 5,151 | 33,529 | 15,224 | 7,806 |
Total Total Growth | 214,405 | 199,295 | 147,637 | 136,699 | 93,292 | 129,960 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 3,672 | 41,165 | 42,554 | 3,617 | 827.53 | 11,598 |
Total Debt Total Debt Growth | 24,381 | 27,503 | 35,941 | 41,422 | 19,530 | 26,074 |
Net Cash (Debt) Net Cash Growth | -20,708 | 13,662 | 6,612 | -37,805 | -18,703 | -14,477 |
Net Cash Growth | - | 106.61% | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -5.29 | 3.46 | 1.67 | -16.06 | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 12,266 | 22,892 | -13,680 | -14,828 | -15,047 | -20,631 |
Capital Expenditures CapEx Growth | -20,505 | -14,210 | -6,809 | -19,405 | -3,280 | -11,710 |
Free Cash Flow Free Cash Flow Growth | -8,239 | 8,681 | -20,490 | -34,233 | -18,327 | -32,341 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 38.78% | 39.74% | 38.44% | 39.91% | 39.83% | 38.04% |
Operating Margin | 8.56% | 10.22% | 6.06% | 4.28% | 3.64% | 2.46% |
Pretax Margin | 5.94% | 8.79% | 3.58% | 4.56% | 4.85% | 2.06% |
Profit Margin | 4.07% | 6.78% | 2.00% | 1.60% | 3.04% | 0.24% |
FCF Margin | -3.84% | 4.36% | -13.88% | -25.04% | -19.65% | -24.88% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 54.23 | 40.07 | 179.29 | - | - | - |
P/FCF Ratio | - | 62.33 | - | - | - | - |
PS Ratio | 2.24 | 2.72 | 3.59 | - | - | - |